Evidence map›Paper›PMID 31242033›Full record

ArticleArteriosclerosis, thrombosis, and vascular biology2019

Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of β-Catenin Signaling.

Lasse D Jensen, Belma Hot, Daniel Ramsköld, Raoul F V Germano, Chika Yokota, Sarantis Giatrellis, Volker M Lauschke, Dirk Hubmacher, Minerva X Li, Mike Hupe and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Arteriosclerosis, thrombosis, and vascular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Cell-to-Cell Signaling Networks at the Blood-Brain Barrier in Health and Disease.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Review
  3. Article
  4. Article
  5. Development of the blood-brain barrier.Development (Cambridge, England) · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Age-Dependent Changes in the Plasma Proteome of Healthy Adults.The journal of nutrition, health & aging · 2020
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 10 institutions in 4 countries.

Lasse D JensenFrom the Department of Medical and Health Sciences, Linköpings Universitet, Linköping, Sweden (L.D.J.).
Belma HotDepartment of Physiology and Pharmacology (B.H., V.M.L., J.K.), Karolinska Institutet, Stockholm, Sweden.
Daniel RamsköldDepartment of Medicine, Solna (D.R.), Karolinska Institutet, Stockholm, Sweden.
Raoul F V GermanoLaboratory of Neurovascular Signaling, Department of Molecular Biology, Université libre de Bruxelles, Belgium (R.F.V.G., B.V.).
Chika YokotaLudwig Institute for Cancer Research Ltd, Stockholm, Sweden (B.H., D.R., C.Y., M.X.L., M.H., R.S., J.M.S., J.K.).
Sarantis GiatrellisDepartment of Cell and Molecular Biology (D.R., S.G., R.S., J.F.), Karolinska Institutet, Stockholm, Sweden.
Volker M LauschkeDepartment of Physiology and Pharmacology (B.H., V.M.L., J.K.), Karolinska Institutet, Stockholm, Sweden.
Dirk HubmacherOrthopaedic Research Laboratories, Department of Orthopaedics, Icahn School of Medicine at Mount Sinai, New York, NY (D.H.).
Minerva X LiLudwig Institute for Cancer Research Ltd, Stockholm, Sweden (B.H., D.R., C.Y., M.X.L., M.H., R.S., J.M.S., J.K.).
Mike HupeLudwig Institute for Cancer Research Ltd, Stockholm, Sweden (B.H., D.R., C.Y., M.X.L., M.H., R.S., J.M.S., J.K.).
Thomas D ArnoldDepartment of Pediatrics, University of California, San Francisco (T.D.A.).
Rickard SandbergDepartment of Cell and Molecular Biology (D.R., S.G., R.S., J.F.), Karolinska Institutet, Stockholm, Sweden.
Jonas FrisénDepartment of Cell and Molecular Biology (D.R., S.G., R.S., J.F.), Karolinska Institutet, Stockholm, Sweden.
Marta TrusohamnDepartment of Medical Biochemistry and Biophysics (M.T., A.M., J.W.-K., D.N.), Karolinska Institutet, Stockholm, Sweden.
Agnieszka MartowiczDepartment of Medical Biochemistry and Biophysics (M.T., A.M., J.W.-K., D.N.), Karolinska Institutet, Stockholm, Sweden.
Joanna Wisniewska-KrukDepartment of Medical Biochemistry and Biophysics (M.T., A.M., J.W.-K., D.N.), Karolinska Institutet, Stockholm, Sweden.
Daniel NyqvistDepartment of Medical Biochemistry and Biophysics (M.T., A.M., J.W.-K., D.N.), Karolinska Institutet, Stockholm, Sweden.
Ralf H AdamsDepartment of Tissue Morphogenesis Max-Planck-Institute for Molecular Biomedicine, University of Münster, Faculty of Medicine, Germany (R.H.A.).
Suneel S ApteDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland Clinic Foundation (S.S.A.).
Benoit VanhollebekeLaboratory of Neurovascular Signaling, Department of Molecular Biology, Université libre de Bruxelles, Belgium (R.F.V.G., B.V.).
Jan M StenmanLudwig Institute for Cancer Research Ltd, Stockholm, Sweden (B.H., D.R., C.Y., M.X.L., M.H., R.S., J.M.S., J.K.).
Julianna KeleDepartment of Physiology and Pharmacology (B.H., V.M.L., J.K.), Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SELudwig Cancer Research · SECleveland Clinic Lerner College of Medicine · USLinköping University · SELund University · SEOrthopaedic Research Laboratories · USUniversité Libre de Bruxelles · BEUniversity of California, San Francisco · USUniversity of Münster · DEWalloon Excellence in Lifesciences and Biotechnology · BE

Funding

Regulation of Skeletal Growth by Soft Tissue Extracellular MatrixR01AR070748 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI HUBMACHER, DIRK · 2017 to 2021
$1.9M
Protease regulation of extracellular networksR01AR053890 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI APTE, SUNEEL S · 2007 to 2011
$1.6M
NIAMS NIH HHS R01 AR053890NIAMS NIH HHS R01 AR070748
6 · The paper itself

Abstract

Objective- The Wnt/β-catenin pathway orchestrates development of the blood-brain barrier, but the downstream mechanisms involved at different developmental windows and in different central nervous system (CNS) tissues have remained elusive. Approach and Results- Here, we create a new mouse model allowing spatiotemporal investigations of Wnt/β-catenin signaling by induced overexpression of Axin1, an inhibitor of β-catenin signaling, specifically in endothelial cells ( Axin1

Indexed as

AnimalsAxin Proteinbeta CateninBlood-Brain BarrierExtracellular MatrixMaleMiceMice, Inbred C57BLProsencephalonSignal TransductionVascular RemodelingWnt Signaling PathwayZebrafishAxin1 protein, mouseAxin Proteinbeta Cateninbasement membraneblood-brain barriercentral nervous systemembryonic developmentendothelial cellsextracellular matrixvasculature

Identifiers

PMID31242033
PMCPMC6597191
OpenAlexW2943869889

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.